Once your product has been listed within clinical compendia and/or clinical pathways, it might seem that your work is done. It is essential, however, to continue to provide clinical and pharmacoeconomic data to priority compendia and pathways organizations, as incremental data is published and supplemental indications are approved, to ensure continued appropriate placement for your products. Our team will work with you to develop a calendar/schedule focused on anticipated data release points to optimize your communications with compendia and pathways organizations. With a team of medical experts, we will leverage our many years of experience and expertise to support the communication of new data and submissions of supplemental applications to clinical compendia and pathways organizations, ensuring access across providers, payers, and patients.